Skip to main content
. 2024 Jun 18;42(24):2908–2917. doi: 10.1200/JCO.23.02099

TABLE A3.

Histopathological Characteristics According to Socioeconomic Status

Characteristic Financial Difficulties Income Educational Level
High Medium Low P Low (lowest tertile) Medium High (highest tertile) P Low Medium High P
Histology, No. (%) .85 .062 .38
 Invasive ca. NST 560 (79.1) 964 (76.9) 2,935 (77.3) 1,417 (79.4) 1,385 (77.7) 1,349 (75.7) 1,689 (77.5) 1,682 (78.2) 1,123 (76.3)
 Invasive lobular ca 85 (12.0) 165 (13.2) 492 (13.0) 210 (11.8) 240 (13.5) 244 (13.7) 279 (12.8) 280 (13.0) 189 (12.8)
 Mixed NST/lobular 63 (8.9) 124 (9.9) 371 (9.8) 157 (8.8) 157 (8.8) 190 (10.7) 212 (9.7) 190 (8.8) 160 (10.9)
Grade, No. (%) .18 .005 .37
 1 119 (17.0) 206 (16.6) 701 (18.6) 294 (16.6) 333 (18.9) 326 (18.4) 401 (18.5) 368 (17.3) 261 (17.9)
 2 377 (53.8) 656 (52.8) 2,032 (53.9) 907 (51.3) 943 (53.5) 972 (54.9) 1,176 (54.3) 1,132 (53.1) 768 (52.6)
 3 205 (29.2) 380 (30.6) 1,034 (27.4) 566 (32.0) 488 (27.7) 473 (26.7) 587 (27.1) 630 (29.6) 431 (29.5)
IHC-defined subtypes, No. (%) .10 .062 .097
 Hormone receptor+/HER2+ 77 (10.9) 156 (12.5) 373 (9.9) 201 (11.3) 184 (10.4) 183 (10.3) 215 (9.9) 230 (10.8) 169 (11.6)
 Hormone receptor–/HER2+ 23 (3.3) 52 (4.2) 147 (3.9) 76 (4.3) 48 (2.7) 82 (4.6) 68 (3.1) 94 (4.4) 63 (4.3)
 Hormone receptor+/HER2– 548 (77.7) 918 (73.6) 2,921 (77.3) 1,333 (74.9) 1,380 (78.0) 1,351 (76.2) 1,700 (78.2) 1,606 (75.1) 1,106 (75.6)
 Hormone receptor–/HER2– 57 (8.1) 122 (9.8) 337 (8.9) 169 (9.5) 158 (8.9) 158 (8.9) 192 (8.8) 208 (9.7) 125 (8.5)

NOTE. Income refers to tertiles of household income per consumption unit. Financial difficulties defined according to how monthly household resources allowed participants to live: high (with difficulty), medium (adequately but on the limit), or low (financially comfortable). Educational level: high (high school and three or more years of higher education), medium (secondary school ± 2 years of professional training), and low (no education or primary education).

Abbreviations: IHC, immunohistochemistry; HER2, human epidermal growth factor receptor 2; NST, no special type.